Citations

Showing 10 of 108081 citations.

Long-term analysis of the palliative benefit of 2-Chlorodeoxyadenosine (2-CdA) for myelofibrosis with myeloid metaplasia
Faoro, L. , Gertz, M. A., Tefferi, Ayalew , Mesa, Ruben A.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 6620-6620

10.1200/jco.2004.22.90140.6620 Get It

Ascorbic acid appears to increase the in vitro specificity and sensitivity of arsenic trioxide to the inhibition of primary myeloid colonies from patients wit
Tefferi, Ayalew , Powell, Heather L., Mesa, Ruben A. , Lasho, Terra L. , Kaufmann, Scott H.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 6619-6619

10.1200/jco.2004.22.90140.6619 Get It

NCCTG trial of concomitant or sequential IL-12 in combination with rituximab in previously treated non-Hodgkin lymphoma patients
Ansell, Stephen M. , Geyer, Susan M. , Jelinek, Diane F., Kurtin, Paul J. , Micallef, Ivana N. , Stella, Philip J., Etzell, Paul S., Erlichman, Charles , Novak, Anne J. , Witzig, Thomas E.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 6591-6591

10.1200/jco.2004.22.90140.6591 Get It

Initial results of a pilot study of epratuzumab and rituximab in combination with CHOP chemotherapy (ER-CHOP) in previously untreated patients with diffuse large B-cell lymphoma (DLBCL)
Micallef, Ivana N. , Gayko, Urte, Cesano, Alessandra, Ansell, Stephen M. , Geyer, Susan M. , Inwards, David J. , Horning, Sandra J., Kahl, Brad S. , Maurer, Matthew J. , Habermann, Thomas M.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 6580-6580

10.1200/jco.2004.22.90140.6580 Get It

Long-term follow-up of a phase I/II trial of radioimmunotherapy (RIT) with yttrium 90 ( 90 Y) ibritumomab tiuxetan for CD20+ B-cell non-Hodgkin's lymphoma (NHL)
Emmanouilides, Christos, Raubitschek, Andrew, Darif, Mohamed, Schilder, Russell J., Wiseman, Gregory A., Gordon, Leo I. , Molina, Aurelia Alañón , White, C. A., Witzig, Thomas E.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 6574-6574

10.1200/jco.2004.22.90140.6574 Get It

Integrated PET based response classification for non-Hodgkin's lymphoma (NHL)
Wiseman, Gregory A., Juweid, Malik E. , Menda, Yusuf , Wooldridge, James E. , Link, Brian K. , Stolpen, Alan H. , Graham, Michael M. , Vose, Julie M.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 6533-6533

10.1200/jco.2004.22.90140.6533 Get It

Proteomic analysis of patients with mantle cell lymphoma identifies Hsp90, and other proteins as potential target(s) for drug therapy
McCormick, D. J., Ansell, Stephen M. , Novak, Anne J. , Stenson, Mary, Krajnik, Kelly L., Ghobrial, Irene M. , Kaufmann, Scott H. , Witzig, Thomas E.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 6530-6530

10.1200/jco.2004.22.90140.6530 Get It

A randomised phase III trial of thalidomide plus dexamethasone versus dexamethasone in newly diagnosed multiple myeloma (E1A00): A trial coordinated by the Eastern Cooperative Oncology Group
Blood, Emily, Vesole, David H., Shepard, Robert, Greipp, Philip R., Rajkumar, S. Vincent

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 6508-6508

10.1200/jco.2004.22.90140.6508 Get It

Results of E1496: A phase III trial of CVP with or without maintenance rituximab in advanced indolent lymphoma (NHL)
Hochster, H. S., Weller, Edie, Gascoyne, Randy D. , Frankel, SR, Horning, SJ, Ryan, Thomas M. , Habermann, Thomas M.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 6502-6502

10.1200/jco.2004.22.90140.6502 Get It

A phase II study of a combination of pemetrexed (Pem) and gemcitabine (Gem) in patients with metastatic breast cancer (MBC): An NCCTG study
X., C., Steen, Preston D. , Rowland, K. M., Niedringhaus, Robert D., Kugler, J. W., Perez, Edith A. , Adjei, Alex A. , Ma, C. X., Ingle, James N.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 639-639

10.1200/jco.2004.22.90140.639 Get It